Evidence map›Paper›PMID 33459778›Full record

ArticleSchizophrenia bulletin2021

Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study.

Paul Kurdyak, Emilie Mallia, Claire de Oliveira, Andre F Carvalho, Nicole Kozloff, Juveria Zaheer, Wanda M Tempelaar, Kelly K Anderson, Christoph U Correll, Aristotle N Voineskos

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis.European psychiatry : the journal of the Association of European Psychiatrists · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul KurdyakCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Emilie MalliaCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Claire de OliveiraCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Andre F CarvalhoCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Nicole KozloffCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Juveria ZaheerCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Wanda M TempelaarCentre for Addiction and Mental Health, Toronto, Ontario, Canada.
Kelly K AndersonInstitute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada.
Christoph U CorrellThe Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY.
Aristotle N VoineskosCentre for Addiction and Mental Health, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is emerging evidence of high mortality rates after the first diagnosis of psychotic disorder. The objective of this study was to estimate the standardized mortality ratio (SMR) in a population-based cohort of individuals with a first diagnosis of schizophrenia-spectrum psychotic disorder (SSD). The cohort included a population-based sample of individuals with a first diagnosis of SSD based on the first diagnosis occurring during hospitalization or in an outpatient setting between 2007 and 2010 in Ontario, Canada. All patients were followed for 5 years after the first diagnosis. The primary outcome was SMR, including all-cause, suicide-related, accidental, and other causes. Between 2007 and 2010, there were 2382 patients in the hospitalization cohort and 11 003 patients in the outpatient cohort. Over the 5-year observation period, 97 (4.1%) of the hospitalization cohort and 292 (2.7%) of the outpatient cohort died, resulting in an SMR of 13.6 and 9.1, respectively. In both cohorts, suicide was the most common cause of death. Approximately 1 in 25 patients with a first diagnosis of SSD during hospitalization, and 1 in 40 patients with a first diagnosis of SSD in an outpatient setting, died within 5 years of first diagnosis in Ontario, Canada. This mortality rate is between 9 and 13 times higher than would be expected in the age-matched general population. Based on these data, timely access to services should be a public health priority to reduce mortality following a first diagnosis of an SSD.

Indexed as

Cause of DeathAdolescentAdultChildEmergency Service, HospitalFemaleHospitalizationHumansInpatientsMaleMiddle AgedOntarioOutpatientsRetrospective StudiesSchizophreniaYoung Adultfirst episodemortalityschizophrenia

Identifiers

PMID33459778
PMCPMC8084423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.